Fig. 7.

CTSS deletion mitigated S-serum-induced C₂C₁₂ myoblast ROS produced, reduction in mitochondrial respiration, cell apoptosis and myotube atrophy. C₂C₁₂ cells were treated with siCTSS and non-targeting control RNA for 48 h and then cultured in 5% NS-serum or 5% S-serum for 24 h. a: Representative fluorescent microscopy images showing intracellular ROS in four experimental groups. Scale bar: 1000 µm. b: The oxygen consumption rate measured using the Seahorse XFp assay in four groups of cells. c: Representative image of TUNEL immunofluorescence (c) and combined quantitative data (d) show the numbers of TUNEL⁺ apoptotic cells in the four experimental groups (n = 5). Yellow arrows: TUNEL⁺ cells. Scale bar: 200 µm. e: Myotubes treated with siCTSS or non-targeting control were cultured in 5% S-serum or NS-serum for 72 h and then subjected to immunofluorescence staining for MHC (NS, SS, siNS, siSS). f: Quantification of the mean diameter of four groups. g: Representative immunoblotting images and (h) quantitative data for LC3B-II/I in the lysates from the four groups (n = 3). Data are mean ± SEM, and p-values were determined by one-way ANOVA followed by Tukey’s post hoc tests (b,d,f,h). NS: C₂C₁₂ cells treated non-targeting control RNA were cultured in 5% NS-serum for 24 h, siNS: CTSS-silenced C₂C₁₂ cells cultured in 5% NS-serum for 24 h, SS: C₂C₁₂ cells treated non-targeting control RNA were cultured in 5% S-serum for 24 h, siSS: CTSS-silenced C₂C₁₂ cells cultured in 5% S-serum for 24 h. *p < 0.05; **p < 0.01; N.S, not significant